Senti Bio to Present at 41st Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI)…
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI)…
Glofitamab is an investigational T-cell engaging bispecific antibody targeting CD20 and CD3 in development for…
PLANO, Texas–(BUSINESS WIRE)–Fortress Solutions, a global provider of critical infrastructure management and support services for…
PLEASANTON, Calif.–(BUSINESS WIRE)–Medallia, Inc., the global leader in customer and employee experience, today announced that…
The new study by LLYC and Más Democracia analyzed polarizing conversations on social media in…
One in Five Investors Started Investing Recently Younger Investors More Comfortable with Risky Investments One…
Global Grant Program and Social Campaign Highlights Young Women Changing the World through Science, Innovation,…
New Attack Surface Management Offering Extends Visibility to Strengthen Cyber Resiliency REDWOOD CITY, Calif.–(BUSINESS WIRE)–#CyberSecurity—Anomali,…
Unique combination of content and AI platform capabilities drives user engagement and healthy behaviors for…
Qualtrics has the largest human sentiment database in the world, helping organizations know their customers…
Restructuring aims to move forward breakeven timeline to the fourth quarter of 2023 AUSTIN, Texas–(BUSINESS…
Dupixent®(dupilumab) approved by European Commission as the first and only targeted medicine indicated for prurigo…
Next Capital Looks to Grow and Enhance Family Office Services NEW YORK–(BUSINESS WIRE)–Next Capital Management…
Cellectis’ Pipeline Overview Cellectis’ Fully Owned & Licensed Product Candidate Pipeline UCART22: anti-tumor activity observed…
Cellectis’ Pipeline Overview Cellectis’ Fully Owned & Licensed Product Candidate Pipeline UCART22: anti-tumor activity observed…
ATLANTA–(BUSINESS WIRE)–#CustomerValueManagement—DecisionLink, the leader in secure, SaaS-based Customer Value Management solutions that simplify and automate…
DALLAS–(BUSINESS WIRE)–It may be the talk of the town, but it’s nothing new. For years,…
NEW YORK–(BUSINESS WIRE)–Davis+Gilbert is pleased to announce the promotion of Andrew Edelen, Paavana Kumar, Samantha…
All patients achieved sustained engraftment and supraphysiological SGSH enzyme levels with median 1.5 years follow-up…
WILMETTE, Ill, Dec. 12, 2022 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical…